View in EDS

Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.

Saved in:
Bibliographic Details
Title: Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.
Authors: Chawla SP; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Jeffrey S; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Pang SS; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Jones RL; Department of Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, U.K., VAN Gool SW; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Huber T; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Kosmal J; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Chawla NS; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Carter R; Department of Research and Development, BostonGene Corporation, Waltham, MA, U.S.A., Simone CB 2nd; Department of Radiation Oncology, New York Proton Center, New York, NY, U.S.A., Nael K; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, U.S.A., Bruckner H; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A., Gattani A; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A., Song PY; NKGen Biotech, Inc., Santa Ana, CA, U.S.A., Hall FL; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A., Gordon EM; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.; egordon@sarcomaoncology.com.; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A.
Source: Anticancer research [Anticancer Res] 2026 Apr; Vol. 46 (4), pp. 2025-2034.
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41895777
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chawla+SP%22">Chawla SP</searchLink>; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Jeffrey+S%22">Jeffrey S</searchLink>; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Pang+SS%22">Pang SS</searchLink>; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Jones+RL%22">Jones RL</searchLink>; Department of Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, U.K.<br /><searchLink fieldCode="AU" term="%22VAN+Gool+SW%22">VAN Gool SW</searchLink>; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+T%22">Huber T</searchLink>; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kosmal+J%22">Kosmal J</searchLink>; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Chawla+NS%22">Chawla NS</searchLink>; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Carter+R%22">Carter R</searchLink>; Department of Research and Development, BostonGene Corporation, Waltham, MA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Simone+CB+2nd%22">Simone CB 2nd</searchLink>; Department of Radiation Oncology, New York Proton Center, New York, NY, U.S.A.<br /><searchLink fieldCode="AU" term="%22Nael+K%22">Nael K</searchLink>; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Bruckner+H%22">Bruckner H</searchLink>; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A.<br /><searchLink fieldCode="AU" term="%22Gattani+A%22">Gattani A</searchLink>; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A.<br /><searchLink fieldCode="AU" term="%22Song+PY%22">Song PY</searchLink>; NKGen Biotech, Inc., Santa Ana, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Hall+FL%22">Hall FL</searchLink>; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Gordon+EM%22">Gordon EM</searchLink>; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.; egordon@sarcomaoncology.com.; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228102988%22">Anticancer research</searchLink> [Anticancer Res] 2026 Apr; Vol. 46 (4), pp. 2025-2034.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>8102988 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-7530 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202507005%22">02507005 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41895777
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21873/anticanres.18091
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2025
    Titles:
      – TitleFull: Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chawla SP
      – PersonEntity:
          Name:
            NameFull: Jeffrey S
      – PersonEntity:
          Name:
            NameFull: Pang SS
      – PersonEntity:
          Name:
            NameFull: Jones RL
      – PersonEntity:
          Name:
            NameFull: VAN Gool SW
      – PersonEntity:
          Name:
            NameFull: Huber T
      – PersonEntity:
          Name:
            NameFull: Kosmal J
      – PersonEntity:
          Name:
            NameFull: Chawla NS
      – PersonEntity:
          Name:
            NameFull: Carter R
      – PersonEntity:
          Name:
            NameFull: Simone CB 2nd
      – PersonEntity:
          Name:
            NameFull: Nael K
      – PersonEntity:
          Name:
            NameFull: Bruckner H
      – PersonEntity:
          Name:
            NameFull: Gattani A
      – PersonEntity:
          Name:
            NameFull: Song PY
      – PersonEntity:
          Name:
            NameFull: Hall FL
      – PersonEntity:
          Name:
            NameFull: Gordon EM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1791-7530
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Anticancer research
              Type: main
ResultId 1